{{Rsnum
|rsid=6044112
|Gene=KIF16B
|Chromosome=20
|position=16555769
|Orientation=plus
|GMAF=0.1795
|Gene_s=KIF16B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 23.9 | 7.1
| HCB | 86.9 | 13.1 | 0.0
| JPT | 91.1 | 8.9 | 0.0
| YRI | 51.7 | 38.8 | 9.5
| ASW | 64.9 | 29.8 | 5.3
| CHB | 86.9 | 13.1 | 0.0
| CHD | 82.4 | 15.7 | 1.9
| GIH | 63.4 | 29.7 | 6.9
| LWK | 53.6 | 40.0 | 6.4
| MEX | 55.2 | 32.8 | 12.1
| MKK | 71.6 | 26.5 | 1.9
| TSI | 69.3 | 27.7 | 3.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=7E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}